As the capabilities and benefits of e-prescribing become more widely known, states will likely continue enacting requirements to drive the uptake of this new technology, explained Doug Hillblom, PharmD, president at Arena Healthcare, LLC.
As the capabilities and benefits of e-prescribing become more widely known, states will likely continue enacting requirements to drive the uptake of this new technology, explained Doug Hillblom, PharmD, president at Arena Healthcare, LLC.
What state mandates and requirements around e-prescribing have been enacted?
We have states that have enacted mandatory e-prescribing for controlled substances. We have states that are mandating e-prescribing, period. I think this is an environment that’s changing rapidly. You are starting to see, and I include this in e-prescribing, electronic prior authorization being talked about in state legislatures, so I think you will be seeing more and more general adoption.
I think what you’re going to be seeing is that over the course of time, as we gain more experience and states gain more experience, health plans, et cetera, that there’ll be kind of a movement to incorporate as many potential components as possible. If state government doesn’t see things being incorporated as quickly as they would like, they will create a mandate. Often time we see people not implementing things because it’s not mandated, so mandates become part of an implementation concept. “I won’t do it until I have to,” well, now you’re going to have to, and that’s why states are doing so many of these legislative actions.
Are there any misconceptions about e-prescribing you would like to clarify?
E-prescribing in general, one of the things I would like people to think about is, it’s not just initiating and receiving a prescription. There are all kinds of components that we think about as a component of e-prescribing, whether that be prior authorization, whether it be looking at formularies, whether it be looking at refills or refill status or fill status. All of those are things that are part of the whole, shall we say, universe of e-prescribing. I think it’s important for people to think about e-prescribing beyond just being a transaction, but rather a group of interactions between the providers.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More